Literature DB >> 32643141

Ion channel inhibition against COVID-19: A novel target for clinical investigation.

Eliano P Navarese1, Rita L Musci2, Lara Frediani3, Paul A Gurbel4, Jacek Kubica5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32643141      PMCID： PMC8016015          DOI： 10.5603/CJ.a2020.0090

Source DB:  PubMed          Journal:  Cardiol J        ISSN： 1898-018X            Impact factor:   2.737


× No keyword cloud information.
  15 in total

Review 1.  Endosome maturation.

Authors:  Jatta Huotari; Ari Helenius
Journal:  EMBO J       Date:  2011-08-31       Impact factor: 11.598

2.  Amiodarone alters late endosomes and inhibits SARS coronavirus infection at a post-endosomal level.

Authors:  Konrad Stadler; Huy Riem Ha; Vincenzo Ciminale; Carlo Spirli; Giulietta Saletti; Marco Schiavon; Daniela Bruttomesso; Laurent Bigler; Ferenc Follath; Andrea Pettenazzo; Aldo Baritussio
Journal:  Am J Respir Cell Mol Biol       Date:  2008-02-28       Impact factor: 6.914

3.  Clathrin-dependent entry of severe acute respiratory syndrome coronavirus into target cells expressing ACE2 with the cytoplasmic tail deleted.

Authors:  Yuuki Inoue; Nobuyuki Tanaka; Yoshinori Tanaka; Shingo Inoue; Kouichi Morita; Min Zhuang; Toshio Hattori; Kazuo Sugamura
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

4.  The role of intraorganellar Ca(2+) in late endosome-lysosome heterotypic fusion and in the reformation of lysosomes from hybrid organelles.

Authors:  P R Pryor; B M Mullock; N A Bright; S R Gray; J P Luzio
Journal:  J Cell Biol       Date:  2000-05-29       Impact factor: 10.539

5.  SARS-CoV fusion peptides induce membrane surface ordering and curvature.

Authors:  Luis G M Basso; Eduardo F Vicente; Edson Crusca; Eduardo M Cilli; Antonio J Costa-Filho
Journal:  Sci Rep       Date:  2016-11-28       Impact factor: 4.379

6.  COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal.

Authors:  Hasan K Siddiqi; Mandeep R Mehra
Journal:  J Heart Lung Transplant       Date:  2020-03-20       Impact factor: 10.247

Review 7.  Coronavirus membrane fusion mechanism offers a potential target for antiviral development.

Authors:  Tiffany Tang; Miya Bidon; Javier A Jaimes; Gary R Whittaker; Susan Daniel
Journal:  Antiviral Res       Date:  2020-04-06       Impact factor: 5.970

8.  Molecular interactions in the assembly of coronaviruses.

Authors:  Cornelis A M de Haan; Peter J M Rottier
Journal:  Adv Virus Res       Date:  2005       Impact factor: 9.937

9.  Amiodarone and metabolite MDEA inhibit Ebola virus infection by interfering with the viral entry process.

Authors:  Cristiano Salata; Aldo Baritussio; Denis Munegato; Arianna Calistri; Huy Riem Ha; Laurent Bigler; Fabrizio Fabris; Cristina Parolin; Giorgio Palù; Ali Mirazimi
Journal:  Pathog Dis       Date:  2015-04-30       Impact factor: 3.166

10.  The SARS-CoV Fusion Peptide Forms an Extended Bipartite Fusion Platform that Perturbs Membrane Order in a Calcium-Dependent Manner.

Authors:  Alex L Lai; Jean K Millet; Susan Daniel; Jack H Freed; Gary R Whittaker
Journal:  J Mol Biol       Date:  2017-10-19       Impact factor: 5.469
View more
  5 in total

1.  Impaired microcirculation function in COVID-19 and implications for potential therapies.

Authors:  Aleksandra Gąsecka; Krzysztof J Filipiak; Miłosz J Jaguszewski
Journal:  Cardiol J       Date:  2020       Impact factor: 2.737

2.  COVID-19: the CaMKII-like system of S protein drives membrane fusion and induces syncytial multinucleated giant cells.

Authors:  Liu Wenzhong; Li Hualan
Journal:  Immunol Res       Date:  2021-08-19       Impact factor: 2.829

3.  Outcomes of Hospitalized COVID-19 Patients Receiving Renin Angiotensin System Blockers and Calcium Channel Blockers.

Authors:  Tatvam T Choksi; Hui Zhang; Thomas Chen; Nikhil Malhotra
Journal:  Am J Nephrol       Date:  2021-04-07       Impact factor: 3.754

4.  Deciphering the Interactions of SARS-CoV-2 Proteins with Human Ion Channels Using Machine-Learning-Based Methods.

Authors:  Nupur S Munjal; Dikscha Sapra; K T Shreya Parthasarathi; Abhishek Goyal; Akhilesh Pandey; Manidipa Banerjee; Jyoti Sharma
Journal:  Pathogens       Date:  2022-02-17

5.  Ion channel inhibition with amiodarone or verapamil in symptomatic hospitalized nonintensive-care COVID-19 patients: The ReCOVery-SIRIO randomized trial.

Authors:  Eliano P Navarese; Przemysław Podhajski; Felicita Andreotti; Giuseppe La Torre; Robert Gajda; Adrian Radziwanowski; Małgorzata Nowicka; Paweł Bukowski; Jacek Gajda; Maciej Omyła; Piotr Lackowski; Maciej Piasecki; Małgorzata Jasiewicz; Paweł Szymański; Łukasz Pietrzykowski; Piotr Michalski; Aldona Kubica; Iwona Urbanowicz; Nicola Orsini; Max Conte; Jarosław Pinkas; Marc A Brouwer; Jacek Kubica
Journal:  Cardiol J       Date:  2022-08-01       Impact factor: 3.487
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.